Health Wire Taiwan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.

Press releases published on July 9, 2026

Jul. 9, 2026

Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis

Indeterminate GlobeNewswire

Jul. 9, 2026

Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 44th Annual Meeting July 15 - 18

Indeterminate GlobeNewswire

Jul. 9, 2026

Heald Expands Access to AI-Powered Glucose Intelligence for Over-the-Counter CGM Users

Indeterminate GlobeNewswire

Jul. 9, 2026

Stereotaxis Completes Acquisition of Robocath

Indeterminate GlobeNewswire

Jul. 9, 2026

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers

Indeterminate GlobeNewswire

Jul. 9, 2026

Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026

Indeterminate GlobeNewswire

Jul. 9, 2026

Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner

Indeterminate GlobeNewswire

Jul. 9, 2026

Sam’s Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members

Indeterminate GlobeNewswire

Jul. 9, 2026

UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots, Recognized for Real-Time, AI-Adaptive Recovery

Indeterminate GlobeNewswire

Jul. 9, 2026

Atsena Therapeutics Selects ATSN-401 Clinical Candidate, a Potential Best-in-Class Gene Therapy for Stargardt Disease

Indeterminate GlobeNewswire

Jul. 9, 2026

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma

Indeterminate GlobeNewswire

Jul. 9, 2026

Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

Indeterminate GlobeNewswire

Jul. 9, 2026

VisCardia Implants First U.S. Patient in RECOVER-HF Pivotal Trial

Indeterminate GlobeNewswire

Jul. 9, 2026

New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management

Indeterminate GlobeNewswire

Jul. 9, 2026

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 9, 2026

Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine

Indeterminate GlobeNewswire

Jul. 9, 2026

CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia

Indeterminate GlobeNewswire

Jul. 9, 2026

Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care

Indeterminate GlobeNewswire

Jul. 9, 2026

NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner

Indeterminate GlobeNewswire

Jul. 9, 2026

What Clinicians Ask About Cartilage Regeneration Supplements: Answering the Clinical Questions Around Cartigenix HP®

Indeterminate GlobeNewswire